|
KR20010086948A
|
|
Pharmaceutical composition for the prevention and treatment of hepatoma
|
|
KR20010086667A
|
|
Pharmaceutical composition for the prevention and treatment of hepatocirrhosis
|
|
KR20010065821A
|
|
A PROCESS FOR THE PREPARATION OF d,l-3-METHYL-CYCLOPENTADECAN-1-ONE
|
|
KR100235896B1
|
|
L-muscone in solid phase and its preparation
|
|
KR100195889B1
|
|
Inclusion complex of l-muscone and its process
|
|
KR100256867B1
|
|
L-muscone as medicament
|
|
KR100249934B1
|
|
Pharmaceutical compositions acting on the circulatory system and process for preparation thereof
|
|
KR100226621B1
|
|
Novel synthetic intermediate of muscone and the preparation thereof
|
|
KR100226622B1
|
|
Novel synthetic intermediate of muscone and the preparation thereof
|
|
KR100256866B1
|
|
Process for the preparation of l-muscone and d-muscone from d,l-muscone
|
|
KR100195888B1
|
|
Process for producing d,l-3-methyl-cyclopentadecan-1-one
|
|
KR100195887B1
|
|
Preparing of beverage
|
|
KR100208427B1
|
|
A process for producing d, l, -3-methyl-cyclopentadecan-1-one
|
|
KR0179320B1
|
|
(+-)-2-(tolylsulfinyl)-cyclopentadecan-1-one and process for preparation thereof
|
|
KR970011273B1
|
|
A process for the preparation of guiryungwon formulations
|
|
KR970011272B1
|
|
A process for the preparation of guiryungwon formulations
|
|
KR920010249B1
|
|
Process for preparing a medicine containing ox bezoar for cardiac fever
|
|
KR920010253B1
|
|
Process for preparing a medicine containing ox bezoar for cardiac fever
|
|
KR920010248B1
|
|
Process for preparing a medicine containing ox bezoar for cardiac fever
|
|
KR920010247B1
|
|
Process for preparing a medicine containing ox bezoar for cardiac fever
|
